CA2636353A1 - Systemes de tests pour l'analyse de polypeptides et de cellules adherant a des silicones - Google Patents

Systemes de tests pour l'analyse de polypeptides et de cellules adherant a des silicones Download PDF

Info

Publication number
CA2636353A1
CA2636353A1 CA002636353A CA2636353A CA2636353A1 CA 2636353 A1 CA2636353 A1 CA 2636353A1 CA 002636353 A CA002636353 A CA 002636353A CA 2636353 A CA2636353 A CA 2636353A CA 2636353 A1 CA2636353 A1 CA 2636353A1
Authority
CA
Canada
Prior art keywords
silicone
polypeptide
adhering
protein
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002636353A
Other languages
English (en)
Inventor
Georg Wick
Nikolaus Wick
Aleksander Backovic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wick Immunologische Diagnostik und Beratung KG
Original Assignee
Georg Wick
Nikolaus Wick
Aleksander Backovic
Idc Immunological Diagnostic And Consulting Kg
Wick, Immunologische Diagnostik U. Beratung Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06001053A external-priority patent/EP1811297A1/fr
Application filed by Georg Wick, Nikolaus Wick, Aleksander Backovic, Idc Immunological Diagnostic And Consulting Kg, Wick, Immunologische Diagnostik U. Beratung Kg filed Critical Georg Wick
Publication of CA2636353A1 publication Critical patent/CA2636353A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
CA002636353A 2006-01-18 2007-01-18 Systemes de tests pour l'analyse de polypeptides et de cellules adherant a des silicones Abandoned CA2636353A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP06001053A EP1811297A1 (fr) 2006-01-18 2006-01-18 Des systèmes de test pour l'analyse de polypeptides et des cellules adhérant à des silicones
EP06001053.5 2006-01-18
US76042606P 2006-01-20 2006-01-20
US60/760,426 2006-01-20
PCT/EP2007/000442 WO2007082757A2 (fr) 2006-01-18 2007-01-18 Systemes de tests pour l’analyse de polypeptides et de cellules adherant a des silicones

Publications (1)

Publication Number Publication Date
CA2636353A1 true CA2636353A1 (fr) 2007-07-26

Family

ID=38042562

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002636353A Abandoned CA2636353A1 (fr) 2006-01-18 2007-01-18 Systemes de tests pour l'analyse de polypeptides et de cellules adherant a des silicones

Country Status (4)

Country Link
JP (1) JP2009524031A (fr)
AU (1) AU2007207089A1 (fr)
CA (1) CA2636353A1 (fr)
WO (1) WO2007082757A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040234602A1 (en) 2001-09-21 2004-11-25 Gina Fischer Polymer release system
WO2003024430A1 (fr) 2001-09-21 2003-03-27 Egalet A/S Systeme a liberation de polymere de morphine
EP1610767B1 (fr) 2003-03-26 2011-01-19 Egalet A/S Systeme de liberation regulee de morphine
EA022609B1 (ru) 2007-02-12 2016-02-29 А1М Фарма Аб Применение свободного фетального гемоглобина в качестве маркера преэклампсии
NZ580972A (en) 2007-06-04 2012-02-24 Egalet Ltd Controlled release pharmaceutical compositions for prolonged effect
ES2543735T3 (es) * 2007-10-22 2015-08-21 Becton Dickinson And Company Artículos médicos revestidos con organopolisiloxano que contienen una disolución de proteína y un tensioactivo no iónico
CA2751667C (fr) 2009-02-06 2016-12-13 Egalet Ltd. Composition a liberation immediate resistant a une maltraitance par prise d'alcool
BR102014004679B1 (pt) * 2014-02-27 2021-04-20 Fundação Oswaldo Cruz método preditivo para diagnóstico diferencial de meningites in vitro, uso de proteínas biomarcadoras, e, kit para diagnóstico diferencial de meningites para determinar se um indivíduo possui meningites bacterianas ou meningites virais
CN104193817B (zh) * 2014-09-05 2016-09-14 桂林英美特生物技术有限公司 人视黄醇结合蛋白的纯化工艺及其多克隆抗体的制备工艺
WO2017137570A1 (fr) 2016-02-10 2017-08-17 Becton Dickinson France Procédé pour évaluer la stabilité de formulation à base de protéine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834215A (en) * 1994-10-05 1998-11-10 The Administrators Of The Tulane Educational Fund Method for detecting antipolymer antibodies and diagnosing silicone related disease (SRD) fibromyalgia and chronic fatigue syndrome (CFS)

Also Published As

Publication number Publication date
JP2009524031A (ja) 2009-06-25
WO2007082757A3 (fr) 2007-09-20
WO2007082757A2 (fr) 2007-07-26
AU2007207089A1 (en) 2007-07-26

Similar Documents

Publication Publication Date Title
CA2636353A1 (fr) Systemes de tests pour l'analyse de polypeptides et de cellules adherant a des silicones
US7776361B2 (en) NELL-1 enhanced bone mineralization
Uruno et al. Haematopoietic lineage cell-specific protein 1 (HS1) promotes actin-related protein (Arp) 2/3 complex-mediated actin polymerization
ES2771475T3 (es) Método in vitro para la detección temprana de una posible inflamación asociada con el rechazo de un trasplante
AU2012219184A1 (en) Method of diagnosing cancer and diagnosis kit using measurement of NK cell activity
Lake et al. CCN5 modulates the antiproliferative effect of heparin and regulates cell motility in vascular smooth muscle cells
US20110135606A1 (en) Test systems for the analysis of polypeptides and cells adhering to silicones
Yu et al. High RIN1 expression is associated with poor prognosis in patients with gastric adenocarcinoma
CA2635906A1 (fr) Materiels et methodes d'identification d'agents modulant la proteine norrin, mimetiques de la proteine norrin, et agent identifies par ces materiels et methodes
Nosala et al. Disc-associated proteins mediate the unusual hyperstability of the ventral disc in Giardia lamblia
Fujikawa et al. Identification of novel splicing variants of protein tyrosine phosphatase receptor type Z
JPWO2008001944A1 (ja) 自己抗体検出用試薬及び自己免疫疾患の診断キット
JP2004500807A (ja) 候補薬剤のスクリーニング方法
Motegi et al. Evidence of a bi-phasic effect of thrombospondin-1 on angiogenesis
Litwin et al. Gelsolin in human colon adenocarcinoma cells with different metastatic potential.
Kanda et al. Pigment epithelium-derived factor inhibits fibroblast-growth-factor-2-induced capillary morphogenesis of endothelial cells through Fyn
JP2003135076A (ja) コラプシン応答メディエータタンパク質１（ｃｒｍｐ−１）
Chintala et al. The effect of type III collagen on migration and invasion of human glioblastoma cell lines in vitro
EP3378947B1 (fr) Utilisation de protéine ed-b dans le diagnostic d'une hyperplasie tissulaire
Nakaoka et al. The inhibitory mechanism of gap junctional intercellular communication induced by polyethylene and the restorative effects by surface modification with various proteins
EP2908876B1 (fr) Proteines recombinantes derivees du collagene a activite de liaison au facteur willebrand
CN109021100A (zh) 特异性识别fsd1蛋白的单克隆抗体
EP4341422A2 (fr) Nouveaux marqueurs biologiques dans le diagnostic de l'endométriose
Yu et al. Dehydrogenase Signal
CN109374892A (zh) 基于热泳对vegf受体的检测系统及方法

Legal Events

Date Code Title Description
FZDE Discontinued